The PAR2 SAM-11 antibody had been used by Sun et al and Zhang et al. [26, 27], and by other groups demonstrating enhanced PAR2 expression in tumour tissue [22, 26, 27, 39–41]. The gene discussed is F2RL1; the disease is neoplasm.